(Q51947455)

English

Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jose A Apud

1

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Michael F Egan

2

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Richard J Wyatt

3

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Schizophrenia Research

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

63

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

1-2

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

151-160

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Intraclass Correlation Coefficient as a Measure of Reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Low serum prolactin and early relapse following neuroleptic withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical predictors of relapse following neuroleptic withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of acute schizophrenia without drugs: an investigation of some current assumptions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic-induced supersensitivity psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing epidemiology of tardive dyskinesia: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug withdrawal in chronic schizophrenic patients: in search of neuroleptic-induced supersensitivity psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900338-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-9964(02)00338-9

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

release_wbbnqgkuane6vhmezihwzaqymq

1 reference

https://api.fatcat.wiki/v0/release/wbbnqgkuane6vhmezihwzaqymq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12892869

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51947455&oldid=1837508267"